André van de Sande

CEO, Xendo Holding B.V.

André van de Sande is a senior executive with 30 years of Life Sciences experience in both mature and emerging markets in Western and Central Europe, Asia Pacific, and Middle East Africa. He has successfully managed the country and regional teams of up to 1100 employees and a turnover of €350 million with Organon International and Schering-Plough Corporation. André has non-executive and advisory board experience with a.o. Lloyds Pharmacies and as chairman of the Dutch Biotech Association BioFarmind (now HollandBio). André has been leading Xendo since 2011. He holds an MBA degree from Tilburg University in The Netherlands, an MSc in Management from Purdue University in the United States, and also completed the supervisory board member program of Nyenrode University. André is fluent in Dutch, English, and German with a working knowledge of French and Hungarian.

Company Blog

July 31, 2018
ProPharma Group Announces New Medical Information Contact Center
ProPharma Group today announces the opening of a new medical information contact center in… Read More
July 16, 2018
ProPharma Group Announces Acquisition of Xendo
ProPharma Group announces the acquisition of Xendo Holding B.V. (“Xendo”), a Netherlands-based provider of… Read More
July 10, 2018
Implementing a Risk-Based Supplier Management Program
What steps should manufacturers take to detect and control supplier issues before commencing the… Read More
More Articles


August 23, 2018
ISPE Midwest Golf Tournament & Dinner
Join us at the ISPE Midwest Chapter’s Annual Golf Tournament and Dinner! This event is always a great af... Read More
September 24, 2018
PDA/FDA Joint Regulatory Conference
In keeping with the focus on putting patients first, this Conference will explore topics that ensure innovatio... Read More
September 26, 2018
ISPE Boston Product Show
Visit the ProPharma Group team during the ISPE Boston Product Show! At this annual event, you’ll see the mos... Read More
All Events
Contact Us